# Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease

> **NCT00291733** · PHASE2 · UNKNOWN · sponsor: **1st Hospital of Social Security Services** · enrollment: 50 (estimated)

## Conditions studied

- Levodopa Induced Dyskinesia

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00291733
- **Lead sponsor:** 1st Hospital of Social Security Services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-05
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2007-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291733, "Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00291733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*